Poor Graft Function clinical trials

Explore recruiting poor graft function clinical trials.

Recruiting poor graft function studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Poor Graft Function trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

CASPER-ATG-IPC 2023-015 : Reinforced prophylaxis of GVH in elderly patients with haematological malignancies receiving haploidentical allogeneic hematopoietic stem cell transplantation: use of a low dose of post-allograft anti-lymphocytic serum.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Poor Graft Function trials by city

Poor Graft Function in Toronto Poor Graft Function in Vancouver Poor Graft Function in Montreal Poor Graft Function in Calgary Poor Graft Function in Edmonton Poor Graft Function in Ottawa Poor Graft Function in Winnipeg Poor Graft Function in Quebec City Poor Graft Function in Hamilton Poor Graft Function in Kitchener Poor Graft Function in London Poor Graft Function in Halifax Poor Graft Function in New York Poor Graft Function in Los Angeles Poor Graft Function in Chicago Poor Graft Function in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease